Association between neurodevelopmental disorders in congenital heart disease and changes in circulatory metabolites and gut microbiota composition

TL;DR

This study explores how heart disease in children is linked to brain development issues through changes in blood chemicals and gut bacteria.

Contribution

The study identifies specific metabolites and gut microbes associated with neurodevelopmental outcomes in children with congenital heart disease.

Findings

Linolenic acid shows positive correlations with neurodevelopmental domains.

The Escherichia genus in gut microbiota is negatively correlated with neurodevelopmental outcomes.

Altered metabolites and gut microbiota are significantly associated with neurodevelopmental disorders in CHD patients.

Abstract

Neurodevelopmental disorder (ND) has emerged as a critical factor affecting the long-term quality of life among patients with congenital heart disease (CHD). The aim of this study was to provide a multi-omics perspective on the mechanisms of ND.

We analyzed the serum metabolome and gut microbiome of children with ND and non-ND (NND) in CHD populations.

In this prospective observational study, we identified associations between serum metabolites, gut microbial, and ND. Linolenic acid was most closely related to neurodevelopmental outcomes, showing positive correlations with multiple neurodevelopmental domains. Among the gut microbiota, the Escherichia genus was most strongly associated with neurodevelopmental outcomes, and negative correlations with neurodevelopmental domains.

This multi-omics study reveals significant association between altered serum metabolites, gut microbiota dysbiosis, and neurodevelopmental outcomes in children with CHD. The microbes and metabolites identified here may contribute to addressing the challenge of ND in the CHD population. Based on our findings, therapeutic strategies to reduce the risk of ND could be developed, including targeted manipulation of the gut microbiota and metabolites.

Figures